01 1Pfizer Ireland Pharmaceuticals Unlimited Company
02 1Upjohn Manufacturing Ireland Unlimited Company
01 2Pfizer Korea
01 2Axitinib
01 2U.S.A
Registrant Name : Pfizer Korea
Registration Date : 2012-08-06
Registration Number : Su189-15-ND
Manufacturer Name : Upjohn Manufacturing Ireland...
Manufacturer Address : Little Island Co. Cork, T45 F627, Ireland
Registrant Name : Pfizer Korea
Registration Date : 2018-02-08
Registration Number : Su87-23-ND
Manufacturer Name : Pfizer Ireland Pharmaceutica...
Manufacturer Address : Ringaskiddy API Plant, Ringaskiddy, Co. Cork, P43 X336, Ireland
17
PharmaCompass offers a list of Axitinib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Axitinib manufacturer or Axitinib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Axitinib manufacturer or Axitinib supplier.
A inlyta manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of inlyta, including repackagers and relabelers. The FDA regulates inlyta manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. inlyta API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of inlyta manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A inlyta supplier is an individual or a company that provides inlyta active pharmaceutical ingredient (API) or inlyta finished formulations upon request. The inlyta suppliers may include inlyta API manufacturers, exporters, distributors and traders.
click here to find a list of inlyta suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a inlyta Drug Master File in Korea (inlyta KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of inlyta. The MFDS reviews the inlyta KDMF as part of the drug registration process and uses the information provided in the inlyta KDMF to evaluate the safety and efficacy of the drug.
After submitting a inlyta KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their inlyta API can apply through the Korea Drug Master File (KDMF).
click here to find a list of inlyta suppliers with KDMF on PharmaCompass.
